Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations

被引：2
|
作者：
Bjornson, Candice [1 ]
Chan, Parco [2 ,3 ]
Li, Abby [2 ,3 ]
Paes, Bosco [4 ]
Lanctot, Krista [2 ,3 ]
Mitchell, Ian [1 ]
机构：
[1] Univ Calgary, Pediat, Calgary, AB, Canada
[2] Univ Toronto, Pharmacol & Toxicol, Toronto, ON, Canada
[3] Sunnybrook Res Inst, MOREr Res Grp, Toronto, ON, Canada
[4] McMaster Univ, Pediat, Hamilton, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Infections; Cystic fibrosis; Infants;
D O I：
10.1183/13993003.congress-2015.PA3625
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3625
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    Vogel, AM
    Lennon, DR
    Broadbent, R
    Byrnes, CA
    Grimwood, K
    Mildenhall, L
    Richardson, V
    Rowley, S
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (06) : 550 - 554
  • [32] Palivizumab for respiratory syncytial virus (RSV) prophylaxis of high-risk infants in a medicaid health maintenance organization (HMO)
    Schaffer, M
    Greenspan, JS
    Amaya, MA
    Vojta, D
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 322A - 322A
  • [33] Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland
    Groves, H. E.
    Jenkins, L.
    Macfarlane, M.
    Reid, A.
    Lynn, F.
    Shields, M. D.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 (04) : 379 - 385
  • [34] Respiratory syncytial virus: Early palivizumab prophylaxis in the NICU
    Bonaparte, J
    Wu, SY
    Pyati, S
    Wilks, A
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 270A - 270A
  • [35] Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology
    Medrano Lopez, C.
    Garcia-Guereta, L.
    Fernandez Pineda, L.
    Malo Concepcion, P.
    Maroto Alvaro, E.
    Santos de Soto, J.
    Lirio Casero, J.
    Suarez Cabrera, P.
    Caballero Martinez, F.
    [J]. ANALES DE PEDIATRIA, 2010, 72 (06): : 432 - 432
  • [36] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection
    Robinson, RF
    Nahata, MC
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (03) : 259 - 264
  • [37] Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations
    B. Paes
    I. Mitchell
    A. Li
    K.L. Lanctôt
    [J]. European Journal of Pediatrics, 2012, 171 : 833 - 841
  • [38] Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations
    Paes, B.
    Mitchell, I.
    Li, A.
    Lanctot, K. L.
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (05) : 833 - 841
  • [39] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
    Robbins, JM
    Tilford, JM
    Gillaspy, SR
    Simpson, DD
    Wheeler, JG
    Shaw, JL
    Jacobs, RF
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
  • [40] Regional impact of prophylaxis with the monoclonal antibody palivizumab on hospitalisations for respiratory syncytial virus in infants
    Duppenthaler, A
    Gorgievski-Hrisobo, M
    Aebi, C
    [J]. SWISS MEDICAL WEEKLY, 2001, 131 (11-12) : 146 - 151
12345